15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 0.5% per year over the past 5 years.
Operating margin has expanded, at 6.4% in the latest year.
Financial health
Total debt ($939M) exceeds cash ($387M); net debt is $551M.
Total debt has grown slower than revenue (-28.4% vs -0.5% per year).
Operating income covered interest expense 2.8× in the latest year.
Total debt is 2.5× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$3.8B
$95M
25.3%
6.4%
8.6%
2.5%
—
$939M
$387M
2024
$3.8B
-$17M
24.5%
4.9%
-1.8%
-0.5%
—
$927M
$311M
2022
$3.5B
-$581M
21.9%
-6.1%
42.1%
-19.0%
—
$2.6B
$319M
2021
$3.9B
-$79M
26.7%
3.5%
9.3%
-2.2%
—
—
$389M
2020
$3.9B
-$269M
26.5%
0.6%
32.5%
-7.4%
—
—
$325M
2019
$4.4B
-$341M
24.2%
-0.6%
64.4%
-9.0%
—
—
$281M
2018
$4.6B
-$531M
19.6%
-7.1%
355.0%
-12.4%
—
—
$458M
2017
$4.6B
-$242M
21.7%
-2.0%
-54.2%
-4.6%
—
—
$543M
2016
$3.3B
-$42M
21.5%
-5.1%
-7.1%
-0.8%
—
—
$653M
2015
—
$74M
—
—
17.9%
3.3%
—
—
$314M
2014
—
$114M
—
—
21.5%
4.9%
—
—
—
2013
—
-$182M
—
—
-30.4%
-8.3%
—
—
—
2012
—
$74M
—
—
9.3%
2.8%
—
—
—
2011
—
$144M
—
—
17.7%
5.7%
—
—
—
2010
—
-$20M
—
—
-2.1%
-0.8%
$222M
—
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$931M
$16M
25.7%
6.2%
1.6%
0.4%
—
$943M
$282M
Mar '26
$892M
$5M
23.9%
3.7%
0.5%
0.1%
—
$939M
$374M
Dec '25
$1.1B
$50M
25.3%
7.5%
4.5%
1.3%
—
$939M
$387M
Sep '25
$945M
$41M
25.9%
7.8%
3.7%
1.1%
—
$934M
$263M
Jun '25
$915M
$12M
25.6%
6.1%
1.1%
0.3%
—
$931M
$295M
Mar '25
$841M
-$8M
24.1%
3.5%
-0.8%
-0.2%
—
$929M
$320M
Dec '24
$989M
$6M
23.4%
4.2%
0.6%
0.2%
—
$927M
$311M
Sep '24
$927M
-$22M
25.5%
5.0%
-2.1%
-0.6%
—
$1.1B
$334M
Jun '24
$940M
$15M
25.9%
7.5%
1.5%
0.4%
—
$1.1B
$360M
Mar '24
$895M
-$15M
23.3%
2.7%
-1.4%
-0.4%
—
$1.1B
$388M
Dec '23
$733M
$22M
30.5%
7.6%
2.1%
0.5%
—
$1.3B
$592M
Sep '23
$895M
-$9M
14.5%
4.1%
-0.9%
-0.2%
—
$1.3B
$440M
Jun '23
$922M
-$677M
24.4%
-0.4%
31.7%
-19.9%
—
$2.2B
$542M
Mar '23
$858M
-$111M
24.4%
-0.2%
7.5%
-3.6%
—
$2574
$246M
Dec '22
$969M
-$149M
22.4%
-4.4%
10.8%
-4.9%
—
$2.6B
$319M
Sep '22
$810M
-$50M
23.9%
0.7%
3.7%
-1.7%
—
—
$128M
Jun '22
$852M
-$199M
18.9%
-10.7%
15.8%
-6.3%
—
—
$250M
Mar '22
$830M
-$183M
22.3%
-10.1%
18.0%
-5.5%
—
—
$225M
Dec '21
$1.1B
-$38M
24.4%
4.7%
4.5%
-1.1%
—
—
$389M
Sep '21
$958M
-$2M
27.1%
4.0%
0.2%
-0.1%
—
—
$216M
Valuation over time
How the market has priced DBD against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 24.4× (Dec '25) to 24.4× (Sep '26).
The price-to-sales ratio has risen from 0.0× (Mar '23) to 0.6× (Sep '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is DBD growing its revenue and profit?
Over the past 5 years, Diebold Nixdorf, Inc's revenue has declined 0.5% per year. These are computed facts, not advice.
How much debt does DBD have?
As of FY2025, Diebold Nixdorf, Inc reported $939M of total debt against $387M of cash; operating income covered interest expense 2.8×.
What is DBD's profit margin?
In FY2025, gross margin was 25.3%, operating margin 6.4%, and net margin 2.5%.
What is DBD's P/E ratio?
As of Sep '26, Diebold Nixdorf, Inc traded at a price-to-earnings ratio of about 24.4× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.